Pulsenmore Valuation Multiples

Discover revenue and EBITDA valuation multiples for Pulsenmore and similar public comparables like Labo Euromedis, Genomtec, Inspira Technologies, Conavi Medical and more.

Pulsenmore Overview

About Pulsenmore

Pulsenmore Ltd is engaged in developing portable ultrasound devices for home use. Its ultrasound scanner dock's with patients' smartphones to deliver images that can be created anywhere, stored and forwarded for clinical review, or shared in an online consultation.


Founded

N/A

HQ

Israel

Employees

63

Financials (FY)

Revenue: $13M
EBITDA: ($5M)

Market Cap

$17M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Pulsenmore Financials

Pulsenmore reported last fiscal year revenue of $13M and negative EBITDA of ($5M).

In the same fiscal year, Pulsenmore generated $11M in gross profit, ($5M) in EBITDA losses, and had net loss of ($5M).


Pulsenmore P&L

In the most recent fiscal year, Pulsenmore reported revenue of $13M and EBITDA of ($5M).

Pulsenmore is unprofitable as of last fiscal year, with gross margin of 84%, EBITDA margin of (41%), and net margin of (40%).

See analyst estimates for Pulsenmore
Last FY202320242025202620272028
Revenue$13M$2M$3M$13M
Gross Profit$11M$743K$1M$11M
Gross Margin84%36%37%84%
EBITDA($5M)($19M)($11M)($5M)
EBITDA Margin(41%)(896%)(346%)(41%)
EBIT Margin(30%)(898%)(437%)(30%)
Net Profit($5M)($20M)($12M)($5M)
Net Margin(40%)(946%)(380%)(40%)
Net Debt($7M)---

Financial data powered by Morningstar, Inc.

Pulsenmore Stock Performance

Pulsenmore has current market cap of $17M.

Market Cap Evolution


Pulsenmore's stock price is $2.61.

Pulsenmore share price decreased by 1.0% in the last 30 days, and by 77.0% in the last year.

Pulsenmore has an EPS (earnings per share) of $-0.81.

See more trading valuation data for Pulsenmore
Market CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$17M-0.7%-1.0%-50.9%-77.0%$-0.81

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Pulsenmore Valuation Multiples

Pulsenmore Financial Valuation Multiples

As of September 4, 2026, Pulsenmore has market cap of $17M.

Pulsenmore has a P/E ratio of (3.2x).

Last FY202320242025202620272028
P/E(3.2x)(0.9x)(1.4x)(3.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Pulsenmore Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Pulsenmore Margins & Growth Rates

In the most recent fiscal year, Pulsenmore reported gross margin of 84%, EBITDA margin of (41%), and net margin of (40%).

See estimated margins and future growth rates for Pulsenmore

Pulsenmore Margins

Last FY20242025202720282029
Gross Margin84%37%84%
EBITDA Margin(41%)(346%)(41%)
EBIT Margin(30%)(437%)(30%)
Net Margin(40%)(380%)(40%)
FCF Margin(83%)(434%)(83%)

Pulsenmore Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth56%306%
Gross Profit Growth63%822%
EBITDA Growth(40%)(52%)
EBIT Growth(24%)(72%)
Net Profit Growth(37%)(58%)
FCF Growth(22%)(23%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Pulsenmore Operational KPIs

Pulsenmore's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for Pulsenmore
Last FY202320242025202620272028
Revenue per Employee$0.2M---
Opex per Employee$0.2M---
S&M Expenses to Revenue13%61%48%13%
G&A Expenses to Revenue2%348%203%2%
R&D Expenses to Revenue43%507%208%43%
Opex to Revenue115%934%474%115%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Pulsenmore Competitors

Pulsenmore competitors include Labo Euromedis, Genomtec, Inspira Technologies, Conavi Medical, CelLBxHealth, Geratherm Medical, Promimic, Scandinavian Real Heart, European Medical Solutions and ViroGates.

Most Pulsenmore public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Labo Euromedis0.1x-6.5x-
Genomtec2906.2x-(8.2x)-
Inspira Technologies48.0x48.0x(1.3x)(1.3x)
Conavi Medical4.4x4.3x(4.9x)-
CelLBxHealth8.5x6.2x(0.7x)(1.4x)
Geratherm Medical0.4x0.5x32.9x5.8x
Promimic3.3x-(50.5x)-
Scandinavian Real Heart--(3.3x)-

This data is available for Pro users. Sign up to see all Pulsenmore competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Pulsenmore

Where is Pulsenmore headquartered?Pulsenmore is headquartered in Israel.
How many employees does Pulsenmore have?As of today, Pulsenmore has over 63 employees.
Is Pulsenmore publicly listed?Yes, Pulsenmore is a public company listed on Tel Aviv Stock Exchange.
What is the stock symbol of Pulsenmore?Pulsenmore trades under PLSM ticker.
When did Pulsenmore go public?Pulsenmore went public in 2021.
Who are competitors of Pulsenmore?Pulsenmore main competitors include Labo Euromedis, Genomtec, Inspira Technologies, Conavi Medical, CelLBxHealth, Geratherm Medical, Promimic, Scandinavian Real Heart, European Medical Solutions, ViroGates.
What is the current market cap of Pulsenmore?Pulsenmore's current market cap is $17M.
What is the current revenue of Pulsenmore?Pulsenmore's last fiscal year revenue is $13M.
Is Pulsenmore profitable?No, Pulsenmore is not profitable.
How many companies Pulsenmore has acquired to date?Pulsenmore hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Pulsenmore has invested to date?Pulsenmore hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Pulsenmore

Lists including Pulsenmore

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial